Cellivery Therapeutics

An Efficient Delivery Technology For Discovery and Development of Breakthrough Medicines

Seoul, South Korea · Founded 2014

Headquarters
Seoul
Employees
11–50
Founded
2014
Business Model
B2B

About

Cellivery Therapeutics is a South Korean biopharmaceutical company founded in March 2014 by Dr. Daewoong Jo. The company's proprietary TSDT (Therapeutic-molecule Systemic Delivery Technology) platform uses advanced cell-penetrating peptide (CPP) sequences to enable intracellular protein delivery, overcoming a fundamental barrier in drug development. Cellivery's pipeline targets Parkinson's disease (iCP-Parkin), inflammation (iCP-SOCS3), bone regeneration (CP-BMP2), sepsis, ataxia, and cancer. The company is listed on the Korean stock exchange (KOSDAQ) and pursues revenue-generating partnerships with global biotech and pharmaceutical companies.

Summary

Cellivery Therapeutics is a Biotech company based in Seoul, South Korea, founded in 2014.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellivery Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/cellivery-therapeutics"><img src="https://indexed.vc/api/badge/company/cellivery-therapeutics" alt="Cellivery Therapeutics on Indexed.vc" width="260" height="76" /></a>